The majority of people infected with SARS-CoV-2 appear to actively shed infectious virus for about…
View More Case study details leukemia patient who shed infectious SARS-CoV-2 for at least 70 days
Four major predictors of COVID-19 emerge in study
In March 2020, New York City, an icon of America, was unfortunately named an early…
View More Four major predictors of COVID-19 emerge in study
New study reveals undetected rare neurodegenerative disorder that looks like Parkinson’s disease
A joint study by the National Neuroscience Institute (NNI) and Singapore General Hospital (SGH) revealed…
View More New study reveals undetected rare neurodegenerative disorder that looks like Parkinson’s disease
Aerosol microdroplets inefficient carriers of COVID-19 virus: study
Aerosol microdroplets, the tiny particles that linger in the air longest after we talk, cough,…
View More Aerosol microdroplets inefficient carriers of COVID-19 virus: study
Study: Malaria-preventive drugs dramatically reduce infections in school children
With nearly half of the world’s population at risk for life-threatening malaria infections, University of…
View More Study: Malaria-preventive drugs dramatically reduce infections in school children
COVID-19 More Common in Pregnant Hispanics Than Other Moms-to-Be: Study
THURSDAY, Oct. 22, 2020 — Hispanic mothers-to-be in the southern United States are almost twice…
View More COVID-19 More Common in Pregnant Hispanics Than Other Moms-to-Be: Study
Study finds lowering nicotine decreases addictiveness of smoking in vulnerable populations
More than 480,000 U.S. deaths per year, as well as diseases affecting 16 million living…
View More Study finds lowering nicotine decreases addictiveness of smoking in vulnerable populations
Cloth coronavirus face masks work — but only if you do this after wearing them, study finds
Fox News Flash top headlines for October 13 Fox News Flash top headlines are here.…
View More Cloth coronavirus face masks work — but only if you do this after wearing them, study finds
Harvard study finds COVID-19 antibodies could last up to four months
Harvard study finds patients who survive severe COVID-19 infections have antibodies for up to four…
View More Harvard study finds COVID-19 antibodies could last up to four months
Vir Biotechnology and GSK Announce Global Expansion to Phase 3 of COMET-ICE Study Evaluating VIR-7831 for the Treatment of COVID-19
06 October 2020 — Vir Biotechnology, Inc. (Nasdaq: VIR) and GlaxoSmithKline plc (LSE/NYSE: GSK) today…
View More Vir Biotechnology and GSK Announce Global Expansion to Phase 3 of COMET-ICE Study Evaluating VIR-7831 for the Treatment of COVID-19